← Back
$VRNA All transactions

Verona Pharma plc

▼ SELL 10b5-1 Plan

$ Value

$1.9M

Shares

204,864

Price

$9

Filed

May 29

Insider

Name

Hahn Mark W

Title

Chief Financial Officer

CIK

0001408502

Roles

Officer

Transaction Details

Transaction Date

2025-05-29

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

12,678,992

Footnotes

Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer. | The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted on January 29, 2025. | The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $9.50 to $9.585 per Ordinary Share, inclusive (or $76.00 to $76.68 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. | The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $9.25 to $9.425 per Ordinary Share, inclusive (or $74.00 to $75.40 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. | The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $9.25 to $9.385 per Ordinary Share, inclusive (or $74.00 to $75.08 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. | Consists of (i) 2,450,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 306,250 ADSs); and (ii) 10,228,992 Ordinary Shares underlying 1,278,624 ADSs.

Filing Info

Accession No.

0001104659-25-054266

Form Type

4

Issuer CIK

0001657312

Hahn Mark W's History

Date Ticker Type Value
2025-10-13 SLNO A $0
2025-10-07 VRNA D
2025-10-07 VRNA M
2025-10-07 VRNA D
2025-10-07 VRNA M
2025-10-07 VRNA M
2025-10-07 VRNA M
2025-10-07 VRNA A
2025-10-07 VRNA M
2025-08-29 VRNA G $0

Other Insiders at VRNA (90d)

No other insider activity at this issuer in the last 90 days.